MedGenesis Therapeutix Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

MedGenesis Therapeutix General Information

Description

Developer of specialty therapeutics intended to provide treatment to patients with serious neurological diseases. The company's therapeutics are established with safety and efficacy profiles for the treatment of serious central nervous system (CNS) diseases while allowing convection-enhanced delivery as a method of direct and targeted delivery of molecules to the relevant area in the central nervous system for effective drug administration, enabling doctors to treat patients suffering from serious cases of Parkinson's.

Contact Information

Website
www.medgenesis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 730 View Street
  • Victoria, British Columbia V8W 3Y7
  • Canada
+1 (250)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 730 View Street
  • Victoria, British Columbia V8W 3Y7
  • Canada
+1 (250)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedGenesis Therapeutix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 22-Apr-2019 Completed Generating Revenue
4. Grant 09-Oct-2012 Completed Generating Revenue
3. Angel (individual) 10-Jan-2012 Completed Generating Revenue
2. Grant 22-Jun-2010 $2.1M $3.2M Completed Generating Revenue
1. Angel (individual) 08-Nov-2006 $3.2M $3.2M Completed Generating Revenue
To view MedGenesis Therapeutix’s complete valuation and funding history, request access »

MedGenesis Therapeutix Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • Pending

  • Expiring in next 12 mo

MedGenesis Therapeutix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009317837-A1 Liposomal composition for convection-enhanced delivery to the central nervous centre Active 21-Nov-2008
AU-2009317837-B2 Liposomal composition for convection-enhanced delivery to the central nervous centre Inactive 21-Nov-2008
US-20110274625-A1 Liposomal composition for convection-enhanced delivery to the central nervous centre Active 21-Nov-2008
US-9295735-B2 Liposomal composition for convection-enhanced delivery to the central nervous centre Inactive 21-Nov-2008
EP-2370058-B1 Liposomal composition for convection-enhanced delivery to the central nervous centre Inactive 21-Nov-2008 A61K49/0084
To view MedGenesis Therapeutix’s complete patent history, request access »

MedGenesis Therapeutix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedGenesis Therapeutix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andreessen Horowitz Venture Capital Minority
Deutsche Parkinson Vereinigung Corporation Minority
Michael J. Fox Foundation Limited Partner Minority
To view MedGenesis Therapeutix’s complete investors history, request access »

Ready to get started?

Request a free trial

MedGenesis Therapeutix FAQs

  • When was MedGenesis Therapeutix founded?

    MedGenesis Therapeutix was founded in 2006.

  • Where is MedGenesis Therapeutix headquartered?

    MedGenesis Therapeutix is headquartered in Victoria, Canada.

  • What is the size of MedGenesis Therapeutix?

    MedGenesis Therapeutix has 3 total employees.

  • What industry is MedGenesis Therapeutix in?

    MedGenesis Therapeutix’s primary industry is Drug Discovery.

  • Is MedGenesis Therapeutix a private or public company?

    MedGenesis Therapeutix is a Private company.

  • What is MedGenesis Therapeutix’s current revenue?

    The current revenue for MedGenesis Therapeutix is .

  • How much funding has MedGenesis Therapeutix raised over time?

    MedGenesis Therapeutix has raised $8.2M.

  • Who are MedGenesis Therapeutix’s investors?

    Andreessen Horowitz, Deutsche Parkinson Vereinigung, and Michael J. Fox Foundation have invested in MedGenesis Therapeutix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »